Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nephrotex Research Group is a clinical research organization (CRO) and site management organization (SMO) specializing in the field of nephrology. Based in Texas and operating as a division of the Texas Kidney Institute, the company partners with major pharmaceutical and biotechnology firms to conduct Phase 1 through Phase 4 clinical trials. Their research efforts focus on identifying and testing novel therapies for kidney-related conditions, including chronic kidney disease, focal segmental glomerulosclerosis, lupus nephritis, and Alport syndrome. Nephrotex maintains specialized facilities in Dallas and Houston, providing the clinical infrastructure and patient access necessary for the development of renal medications and medical devices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nephrotex Research Group.